Citigroup upgraded CME Group Inc (CME) to a Buy rating from Neutral on September 24, 2025. The stock is currently priced at $275.37.
This upgrade reflects a more optimistic view on CME Group's prospects, suggesting improved fundamentals or better-than-expected business performance. CME Group operates a derivatives marketplace, offering a wide range of futures and options products for risk management. Headquartered in Chicago, Illinois, the company has a market capitalization of $97.9 billion and employs 3,760 full-time staff.
CME Group's financial snapshot includes a P/E ratio of 26.01, an EPS of 10.45, and a dividend yield of 183.5%. The company is scheduled to report its next earnings on July 21, 2026, with an estimated EPS of $2.97 and revenue expected to reach $1.7 billion.
Analyst consensus indicates a Buy rating, with 5 Strong Buy, 7 Buy, 7 Hold, 3 Sell, and no Strong Sell recommendations as of November 1, 2025. Recent analyst actions include Citigroup's upgrade and a maintenance of ratings from other firms, highlighting the evolving sentiment around the stock.
Investors should consider various factors, including company fundamentals and industry trends, when interpreting analyst ratings and price targets.